Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

Warren W. Kretzschmar | Robert M. Maier | P. O’Reilly | P. Visscher | N. Wray | I. Deary | E. Mihailov | J. Marchini | H. Stefánsson | S. Cichon | S. Steinberg | E. Sigurdsson | T. Thorgeirsson | M. Rietschel | T. Werge | M. Nöthen | K. Stefánsson | L. Kassem | F. McMahon | J. Potash | T. Schulze | M. Gill | N. Craddock | M. Owen | M. O’Donovan | P. Sullivan | M. Leboyer | J. Rice | K. Tansey | Jianxin Shi | Z. Kutalik | M. McCarthy | P. Zandi | M. Alda | C. Nievergelt | J. Kelsoe | I. Hickie | A. Beekman | M. Weissman | G. Breen | P. McGuffin | C. Lewis | M. Frye | I. Kohane | H. Völzke | Yunpeng Wang | W. Thompson | S. Mostafavi | P. Falkai | W. Maier | J. Smoller | G. Crawford | J. Fullerton | A. McIntosh | M. Preisig | F. Bellivier | G. Laje | S. McElroy | P. Mitchell | P. Schofield | B. Penninx | V. Arolt | G. Willemsen | A. Metspalu | T. Esko | F. Tekola-Ayele | G. Montgomery | L. Milani | D. Blackwood | J. Knowles | J. Kahn | D. Mehta | J. Wellmann | A. Amare | U. Dannlowski | J. Biernacka | B. Baune | K. Kendler | D. Posthuma | R. Perlis | P. McGrath | D. Porteous | D. Levinson | S. Paciga | M. Maj | D. Nyholt | J. Hottenga | P. Magnusson | N. Pedersen | J. Smit | G. Lewis | M. Bauer | A. Pfennig | P. Grof | K. Domschke | N. Akula | S. Bacanu | A. Heath | O. Mors | J. Hauser | R. Uher | E. Derks | P. Mortensen | A. Børglum | M. Nordentoft | D. Hougaard | M. Mattheisen | H. Grabe | G. Homuth | A. Teumer | S. Medland | B. Müller-Myhsok | S. Van der Auwera | J. Bryois | S. Ripke | Qingqin S. Li | H. Xi | A. Abdellaoui | D. Umbricht | B. Riley | S. Hamilton | G. Davies | Jian Yang | H. Tiemeier | C. Hayward | P. Lind | W. Peyrot | K. Berger | P. Madden | Danny J. Smith | B. Webb | Y. Milaneschi | T. Andlauer | J. Grove | C. Schaefer | E. Domenici | J. Rybakowski | E. Binder | F. Goes | C. Dolan | R. Schoevers | B. König | H. Finucane | B. Couvy-Duchesne | M. Nauck | R. Hashimoto | E. Vieta | A. Wright | P. Hoffmann | Yang Wu | G. Rouleau | H. Mbarek | Y. Hsu | R. Jansen | C. Middeldorp | S. Kittel-Schneider | M. Landén | E. Agerbo | J. Bybjerg-Grauholm | C. Hansen | C. Pedersen | M. Pedersen | A. Reif | S. Papiol | V. Escott-Price | A. V. van Hemert | L. Hall | E. Byrne | T. Eley | J. Painter | L. Colodro-Conde | S. Witt | F. Degenhardt | A. Forstner | S. Herms | G. Turecki | Futao Zhang | J. Aubry | P. Monteleone | J. Coleman | Hsi-Chung Chen | E. Jorgenson | M. Adams | D. Macintyre | N. Mullins | G. Pistis | S. Jamain | B. Étain | P. Thomson | H. Teismann | D. MacKinnon | F. Mondimore | B. Schweizer | J. R. DePaulo | T. Bigdeli | M. Nivard | L. Shen | Tadafumi Kato | N. Ozaki | P. Qvist | F. Streit | J. Treutlein | M. Trzaskowski | P. Shilling | J. Strohmaier | M. Schalling | U. Ösby | L. Backlund | L. Frisén | S. Lucae | H. Oskarsson | J. Frank | T. Hansen | M. Ising | Stanley I. Shyn | A. Hofmann | N. Direk | B. Ng | E. Dunn | C. Cruceanu | C. Simhandl | E. Jiménez | A. Bhattacharjee | S. Kloiber | M. Mitjans | S. Mirza | P. Czerski | B. Arias | T. Novák | M. Grigoroiu-Serbanescu | T. Air | H. Buttenschøn | I. Kusumi | A. Viktorin | N. Cai | E. Castelao | Farnush Farhadi Hassan Kiadeh | Carsten Horn | J. Kraft | J. Krogh | Yihan Li | E. Pettersson | J. Quiroz | M. Rivera | E. Schulte | M. Traylor | V. Trubetskoy | S. Weinsheimer | A. Tortorella | S. Leckband | A. Squassina | T. Stamm | F. Colom | J. Garnham | C. O’Donovan | C. Slaney | P. Cervantes | U. Heilbronner | A. Benabarre | M. Manchia | L. Hou | M. Adli | K. Akiyama | R. Ardau | S. Bengesser | A. Birner | C. Brichant‐Petitjean | C. Chillotti | S. Clark | A. Dayer | S. Gard | S. Kliwicki | C. Lavebratt | K. Schubert | G. Severino | T. Shekhtman | E. Reininghaus | M. Del Zompo | E. D. de Geus | J. Veeh | N. Dalkner | W. Kretzschmar | Jane Christensen | Katzutaka Shimoda | N. R. S. M. M. E. M. A. M. J. E. Wray Ripke Mattheisen Trzaskowski Byrne Abdellaoui | P. Stopková | Po-Hsiu Kuo | A. Uitterlinden | S. Gordon | D. Boomsma | Micah Cearns | Lina Martinsson | Héléna A. Gaspar | Grant C. B. Sinnamon | Toni‐Kim Clarke | Roseann E. Peterson | N. Martin | Marie Bækvad-Hansen | N. Martin | C. Lewis

[1]  J Scott,et al.  An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes , 2020, Bipolar disorders.

[2]  P. O’Reilly,et al.  PRSice-2: Polygenic Risk Score software for biobank-scale data , 2019, GigaScience.

[3]  J. Geddes,et al.  A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder , 2019, Acta psychiatrica Scandinavica.

[4]  A. McIntosh,et al.  Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression , 2019, Molecular Psychiatry.

[5]  A. Tanskanen,et al.  Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder , 2018, JAMA psychiatry.

[6]  L. Marshall,et al.  Bipolar disorders , 2018, Nature Reviews Disease Primers.

[7]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[8]  Janice M. Fullerton,et al.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study , 2017, JAMA psychiatry.

[9]  A. Amare,et al.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry , 2017, EPMA Journal.

[10]  Jakob Grove,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[11]  A. Tanskanen,et al.  Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. , 2017, The lancet. Psychiatry.

[12]  M. Abou-Saleh,et al.  Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression , 2017, International Journal of Bipolar Disorders.

[13]  M. Leboyer,et al.  Clinical factors associated with lithium response in bipolar disorders , 2017, The Australian and New Zealand journal of psychiatry.

[14]  John P. Rice,et al.  Genetic effects influencing risk for major depressive disorder in China and Europe , 2017, Translational Psychiatry.

[15]  G. Goodwin,et al.  Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder. , 2017, The British journal of psychiatry : the journal of mental science.

[16]  A. Amare,et al.  The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies , 2017, Translational Psychiatry.

[17]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[18]  T. Vos,et al.  The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013 , 2016, Bipolar disorders.

[19]  M. Makmor-Bakry,et al.  Long term use of lithium and factors associated with treatment response among patients with bipolar disorder. , 2016, Psychiatria Danubina.

[20]  M. Bauer,et al.  The Essential Guide to Lithium Treatment , 2016 .

[21]  O. Andreassen,et al.  The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample , 2016, BMC Psychiatry.

[22]  J. Licinio,et al.  Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries , 2016, Molecular Psychiatry.

[23]  Janice M. Fullerton,et al.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study , 2016, The Lancet.

[24]  R. Porter,et al.  Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders , 2015, The Australian and New Zealand journal of psychiatry.

[25]  Beth Wilmot,et al.  Edinburgh Explorer Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture , 2022 .

[26]  Y. Fang,et al.  Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. , 2015, The Journal of clinical psychiatry.

[27]  J. Geddes,et al.  Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis , 2014, International Journal of Bipolar Disorders.

[28]  N. Wray,et al.  Research review: Polygenic methods and their application to psychiatric traits. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[29]  Seena Fazel,et al.  Risks of all‐cause and suicide mortality in mental disorders: a meta‐review , 2014, World psychiatry : official journal of the World Psychiatric Association.

[30]  T. Bschor.  Lithium in the Treatment of Major Depressive Disorder , 2014, Drugs.

[31]  M. Bauer,et al.  Role of Lithium Augmentation in the Management of Major Depressive Disorder , 2014, CNS Drugs.

[32]  T. Su,et al.  Variant GADL1 and response to lithium therapy in bipolar I disorder. , 2014, The New England journal of medicine.

[33]  Naomi R. Wray,et al.  Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report , 2013, PloS one.

[34]  K. Fountoulakis,et al.  Treatment of mixed bipolar states. , 2012, The international journal of neuropsychopharmacology.

[35]  E. Vieta,et al.  Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder , 2012, European Neuropsychopharmacology.

[36]  E. Alevizos,et al.  Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. , 2012, Psychiatrike = Psychiatriki.

[37]  P. Das,et al.  The science and practice of lithium therapy , 2012, The Australian and New Zealand journal of psychiatry.

[38]  P. Andersen,et al.  Predictors of excellent response to lithium: results from a nationwide register-based study , 2011, International clinical psychopharmacology.

[39]  M. Breakspear,et al.  Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees. , 2011, The British journal of psychiatry : the journal of mental science.

[40]  M. Alda,et al.  Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. , 2010, Bipolar disorders.

[41]  S. Cichon,et al.  The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. , 2010, Neuropsychobiology.

[42]  M. Alda,et al.  Can body mass index help predict outcome in patients with bipolar disorder? , 2009, Bipolar disorders.

[43]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[44]  H. Lôo.  [On bipolar disorder]. , 2008, L'Encephale.

[45]  M. Alda,et al.  Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. , 2007, Journal of affective disorders.

[46]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[47]  M. Alda,et al.  A Consecutive Series of Treated Affected Offspring of Parents with Bipolar Disorder: Is Response Associated with the Clinical Profile? , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[48]  M. Bauer,et al.  Efficacy and mechanisms of action of lithium augmentation in refractory major depression. , 2006, Current pharmaceutical design.

[49]  E. Vieta,et al.  Clinical and therapeutic implications of predominant polarity in bipolar disorder. , 2006, Journal of affective disorders.

[50]  N. Kleindienst,et al.  Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. , 2005, Bipolar disorders.

[51]  A. Heinz,et al.  Lithium Augmentation Therapy in Refractory Depression: Clinical Evidence and Neurobiological Mechanisms , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[52]  M. Alda,et al.  Is response to prophylactic lithium a familial trait? , 2002, The Journal of clinical psychiatry.

[53]  A. Berghöfer,et al.  Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. , 2000, The American journal of psychiatry.

[54]  A. Leon,et al.  A history of substance abuse complicates remission from acute mania in bipolar disorder. , 1999, The Journal of clinical psychiatry.

[55]  M. Bauer,et al.  Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. , 1999, Journal of clinical psychopharmacology.

[56]  D. Altman,et al.  Multiple significance tests: the Bonferroni method , 1995, BMJ.

[57]  M. Alda,et al.  Lithium response and genetics of affective disorders. , 1994, Journal of affective disorders.

[58]  P. Grof,et al.  Lithium response and the sequence of episode polarities: Preliminary report on a hamilton sample , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  M. Bauer,et al.  Practical Management of Lithium , 2016 .

[60]  M. Alda,et al.  Insulin resistance and outcome in bipolar disorder. , 2015, The British journal of psychiatry : the journal of mental science.

[61]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[62]  A. Steinacker,et al.  A Spice Study of Silicon Sensor Strip Noise on Long Ladders , 2011 .

[63]  M. Bauer,et al.  Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. , 2000, Journal of clinical psychopharmacology.